Hodgkin’s lymphoma in a patient with Jo-1 syndrome

By Adam Alexander   Grohé Christian   Stier Sebastian   Gattenlöhner Stefan   Balta Zeynep   Büttner Reinhard   Gütgemann Ines  

Virchows Archiv, Vol. 451, Iss. 1, 2007-07 ,pp. : 101-104

Springer Publishing Company

Access to resources Recommend Favorite

Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin’s disease

By Brosteanu O.  

Annals of Hematology, Vol. 83, Iss. 3, 2004-03 ,pp. : 176-182

Springer Publishing Company

Access to resources Recommend Favorite

Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment

By Page Eric   Assouline David   Durand Catherine   Brun Odile   Coeffic David   Fric Danièle   Garnier Claire   Leyronnas Cécile   Alcalay Véronique   Aguilaniu Bernard  

Annals of Hematology, Vol. 85, Iss. 12, 2006-12 ,pp. : 857-861

Springer Publishing Company

Access to resources Recommend Favorite

Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin’s disease

By Kömürcü Ş.   Özet A.   Altundag M.   Arpaci F.   Öztürk B.   Celasun B.   Tezcan Y.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 57-58

Springer Publishing Company

Access to resources Recommend Favorite

What is the Best Option to Cure Patients with Resistant/Relapsing Hodgkin’s Disease?

By  

Current Stem Cell Research & Therapy, Vol. 1, Iss. 3, 2006-09 ,pp. : 419-424

Bentham Science Publishers

Access to resources Recommend Favorite